Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-02-14 3:31 pm Purchase | 13G | ARCHER AVIATION INC ACHR | CVI Investments Inc. | 1,820,030 1.2% | 1,820,030 (New Position) | View |
| 2022-02-14 3:30 pm Purchase | 13G | CREATIVE MED TECHNOLOGY HLDGS CELZ | CVI Investments Inc. | 332,317 4.9% | 5,817 (+1.78%) | View |
| 2022-02-14 3:30 pm Sale | 13G | EVOFEM BIOSCIENCES INC EVFM | CVI Investments Inc. | 10,000,000 5.8% | -5,567,602 (-35.76%) | View |
| 2022-02-14 3:29 pm Sale | 13G | VISLINK TECHNOLOGIES INC P VISL | CVI Investments Inc. | 1,515,151 3.2% | -1,515,151 (-50.00%) | View |
| 2022-02-14 3:29 pm Purchase | 13G | MALLARD ACQUISITION CORP MACU | CVI Investments Inc. | 899,999 6.5% | 899,999 (New Position) | View |
| 2022-02-14 3:29 pm Sale | 13G | PULMATRIX INC PULM | CVI Investments Inc. | 2,461,111 4.2% | -1,038,889 (-29.68%) | View |
| 2022-02-14 3:28 pm Purchase | 13G | ENVVENO MED CORP COM NVNO | CVI Investments Inc. | 280,357 2.9% | 280,357 (New Position) | View |
| 2022-02-14 3:28 pm Purchase | 13G | VICKERS VANTAGE CORP I SHS VCKA | CVI Investments Inc. | 749,600 4.3% | 749,600 (New Position) | View |
| 2022-02-14 3:27 pm Purchase | 13G | EBANG INTL HLDGS INC EBON | CVI Investments Inc. | 10,300,000 6.9% | 3,300,000 (+47.14%) | View |
| 2022-02-14 3:27 pm Sale | 13G | CALADRIUS BIOSCIENCES INC CLBS | CVI Investments Inc. | 1,575,000 2.6% | -1,425,000 (-47.50%) | View |
| 2022-02-14 3:26 pm Unchanged | 13G | ENESSERE CAP ACQUISITION CORP BENE | CVI Investments Inc. | 0 0% | 0 (Unchanged) | View |
| 2022-02-14 3:26 pm Purchase | 13G | ANTELOPE ENTERPRISE HOLDINGS L AEHL | CVI Investments Inc. | 311,682 4.9% | 115,603 (+58.96%) | View |
| 2022-02-14 3:25 pm Sale | 13G | NEOVASC INC NO PAR NVCN | CVI Investments Inc. | 2,562,500 3.7% | -1,437,500 (-35.94%) | View |
| 2022-02-14 3:25 pm Purchase | 13G | TG VENTURE ACQ.CORP COM TGVC | CVI Investments Inc. | 538,069 4.7% | 538,069 (New Position) | View |
| 2022-02-14 3:25 pm Purchase | 13G | PERASO INC PRSO | CVI Investments Inc. | 7,375 0.1% | 7,375 (New Position) | View |
| 2022-02-14 3:24 pm Purchase | 13G | CLARUS THERAPEUTICS HLDGS INC CRXT | CVI Investments Inc. | 264,407 1.1% | 264,407 (New Position) | View |
| 2022-02-14 3:24 pm Sale | 13G | PYXIS TANKERS INC PXS | CVI Investments Inc. | 87,047 0.2% | -2,770,096 (-96.95%) | View |
| 2022-02-14 3:23 pm Sale | 13G | CYREN LTD CYRN | CVI Investments Inc. | 0 0% | -4,500,000 (Position Closed) | View |
| 2022-02-14 3:23 pm Unchanged | 13G | CAN-FITE BIOPHARMA LTD SPONSOR CANF | CVI Investments Inc. | 23,161,650 3.7% | 0 (Unchanged) | View |
| 2022-02-14 3:23 pm Sale | 13G | VIRPAX PHARMACEUTICALS INC VRPX | CVI Investments Inc. | 0 0% | -1,000,000 (Position Closed) | View |